TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.
暂无分享,去创建一个
Jason Baardsnes | A. Hinck | M. O’Connor-McCourt | C. Hinck | J. Baardsnes | Andrew P Hinck | Maureen D O'Connor-McCourt | Cynthia S Hinck
[1] W. Stites,et al. Protein−Protein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis , 1997 .
[2] M. O’Connor-McCourt,et al. Real-time Monitoring of the Interactions of Transforming Growth Factor-β (TGF-β) Isoforms with Latency-associated Protein and the Ectodomains of the TGF-β Type II and III Receptors Reveals Different Kinetic Models and Stoichiometries of Binding* , 2001, The Journal of Biological Chemistry.
[3] V. Saudek,et al. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.
[4] K. Cutroneo. TGF‐β–induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[5] M. Ferguson,et al. Transforming growth factor-beta 3 is required for secondary palate fusion. , 1995, Nature genetics.
[6] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[7] K. Miyazono,et al. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling. , 2007, Oncogene.
[8] G. Boivin,et al. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.
[9] G. Proetzel,et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.
[10] C. Hammann,et al. Comparative thermodynamic analysis of cyclic nucleotide binding to protein kinase A , 2007, Biological chemistry.
[11] D. Winzor,et al. Interpretation of the temperature dependence of equilibrium and rate constants , 2006, Journal of molecular recognition : JMR.
[12] M. Grütter,et al. The crystal structure of TGF‐β3 and comparison to TGF‐β2: Implications for receptor binding , 1996, Protein science : a publication of the Protein Society.
[13] R. Hodges,et al. Real-time monitoring of the interactions of two-stranded de novo designed coiled-coils: effect of chain length on the kinetic and thermodynamic constants of binding. , 2003, Biochemistry.
[14] J. Massagué,et al. Betaglycan presents ligand to the TGF beta signaling receptor. , 1993, Cell.
[15] R. Derynck. TGF-beta-receptor-mediated signaling. , 1994, Trends in biochemical sciences.
[16] M. Sporn,et al. Transforming growth factor beta. , 1988, Advances in cancer research.
[17] Tudor Arvinte,et al. Conformation and Self-association of Human Recombinant Transforming Growth Factor-β3 in Aqueous Solutions* , 1999, The Journal of Biological Chemistry.
[18] A. Hinck,et al. Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor. , 2006, Journal of molecular biology.
[19] W. Kwiatkowski,et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. , 2003, Molecular cell.
[20] M. Grütter,et al. An unusual feature revealed by the crystal structure at 2.2 Å resolution of human transforming growth fact or-β2 , 1992, Nature.
[21] D. Winzor,et al. Interpretation of the temperature dependence of rate constants in biosensor studies. , 2005, Analytical biochemistry.
[22] A. Hinck,et al. Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex. , 2002, Nature structural biology.
[23] F. López‐Casillas,et al. Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent. , 2001, The Biochemical journal.
[24] D G Myszka,et al. The ABRF-MIRG'02 study: assembly state, thermodynamic, and kinetic analysis of an enzyme/inhibitor interaction. , 2003, Journal of biomolecular techniques : JBT.
[25] T. Jardetzky,et al. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.
[26] J. Massagué,et al. Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. , 1990, The Journal of biological chemistry.
[27] D. Davies,et al. Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. , 1992, Science.
[28] R Wieser,et al. Mechanism of activation of the TGF-beta receptor. , 1994, Nature.
[29] A. Hinck,et al. Sequential resonance assignments of the extracellular ligand binding domain of the human TGF-beta type II receptor. , 2000, Journal of biomolecular NMR.
[30] A. Hinck,et al. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. , 2008, Molecular cell.
[31] M. O’Connor-McCourt,et al. Enhancement of the Antagonistic Potency of Transforming Growth Factor-β Receptor Extracellular Domains by Coiled Coil-induced Homo- and Heterodimerization* , 2004, Journal of Biological Chemistry.
[32] J. Massagué,et al. TGF beta signals through a heteromeric protein kinase receptor complex. , 1992, Cell.